These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Blepharospasm as a Manifestation of Peak of Dose Dyskinesia in Parkinson Disease. Ramírez-Gómez CC; Zúñiga-Ramírez C; Contartese ML; Montilla V; Gramajo J; Micheli F Clin Neuropharmacol; 2019; 42(1):14-16. PubMed ID: 30649026 [TBL] [Abstract][Full Text] [Related]
4. Meige disease: striatal dopaminergic preponderance. Tolosa ES; Lai C Neurology; 1979 Aug; 29(8):1126-30. PubMed ID: 379689 [TBL] [Abstract][Full Text] [Related]
5. Tardive syndrome and Parkinson's disease responsive to concomitant tetrabenazine and levodopa therapy. Kurtis MM; Franch O Parkinsonism Relat Disord; 2011 Dec; 17(10):774-6. PubMed ID: 21733737 [No Abstract] [Full Text] [Related]
6. Pharmacological strategies for controlling motor fluctuations in Parkinson's disease. Ruggieri S; Carta A; Stocchi F; Antonini A; Bellantuono P; Monge A Funct Neurol; 1988; 3(4):471-9. PubMed ID: 3072281 [No Abstract] [Full Text] [Related]
7. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations. Sage JI; Mark MH Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688 [TBL] [Abstract][Full Text] [Related]
8. Aripiprazole Can Improve Apraxia of Eyelid Opening in Parkinson's Disease. Tokisato K; Fukunaga K; Tokunaga M; Watanabe S; Nakanishi R; Yamanaga H Intern Med; 2015; 54(23):3061-4. PubMed ID: 26631893 [TBL] [Abstract][Full Text] [Related]
9. On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics. Nutt JG Ann Neurol; 1987 Oct; 22(4):535-40. PubMed ID: 3324948 [TBL] [Abstract][Full Text] [Related]
10. Progressive supranuclear palsy (report of 4 cases with particular reference to blepharospasm and levodopa therapy). Singh S; Smith BH; Lal A Neurol India; 1974 Jun; 22(2):65-71. PubMed ID: 4437701 [No Abstract] [Full Text] [Related]
11. Treatment of benign essential blepharospasm with finasteride: a case report. Bortolato M; Cannas A; Solla P; Puligheddu M; Muroni A; Marrosu F Clin Neuropharmacol; 2010 Jul; 33(4):207-8. PubMed ID: 20386102 [TBL] [Abstract][Full Text] [Related]
13. Use of botulinum in the treatment of 100 patients with blepharospasm. Mauriello JA; Coniaris H N J Med; 1987 Jan; 84(1):43-4. PubMed ID: 3472105 [No Abstract] [Full Text] [Related]
14. Treatment of blepharospasm with botulinum A toxin. Kim YD; Levine MR Korean J Ophthalmol; 1987 Dec; 1(2):102-8. PubMed ID: 3508221 [No Abstract] [Full Text] [Related]
15. Treatment of benign essential blepharospasm with cyproheptadine. Fasanella RM; Aghajanian GK N Engl J Med; 1990 Mar; 322(11):778. PubMed ID: 2308610 [No Abstract] [Full Text] [Related]
16. Motor response complications in advanced Parkinson's disease. Chase TN; Juncos JL; Fabbrini G; Mouradian MM Funct Neurol; 1988; 3(4):429-36. PubMed ID: 3072278 [No Abstract] [Full Text] [Related]
19. Dopa-responsive camptocormia in a patient with multiple system atrophy. Song IU; Kim JS; Lee KS Parkinsonism Relat Disord; 2008; 14(2):161-3. PubMed ID: 17433754 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of blepharospasm with botulinum A toxin injections]. Bihari K Orv Hetil; 1988 Jan; 129(2):67-8. PubMed ID: 3344134 [No Abstract] [Full Text] [Related] [Next] [New Search]